Fidson, one of Nigeria’s biggest drugmakers has grown its profit after tax by 18 percent despite finance cost pressures in the first quarter of 2023.
The healthcare firm grew its profit after tax to N1.36 billion in the first quarter of 2023 from N1.15 billion in the first quarter of 2022.
F
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Folake Balogun
Folake Balogun is a tech journalist covering Africa’s fast-growing digital economy with a strong focus on incisive analysis of startup trends, venture capital, and fintech innovation, while also exploring emerging technologies such as artificial intelligence and the future of connectivity by highlighting their economic and social impact.
